Subject category:
Strategy and General Management
Published by:
Stanford Business School
Version: 20 June 2012
Length: 4 pages
Data source: Field research
Share a link:
https://casecent.re/p/122422
Write a review
|
No reviews for this item
This product has not been used yet
Abstract
On June 12, 2008, Invitrogen and Applied Biosystems announced plans to merge. The combined company was to be renamed Life Technologies (NASDAQ: LIFE). Invitrogen offered to acquire Applied Biosystems for $6.7 billion in cash and stock. AB shareholders would receive $38 per share in cash and stock, representing a 17 percent premium over the share's closing price on Wednesday, June 11, 2008.
Other setting(s):
2012
About
Abstract
On June 12, 2008, Invitrogen and Applied Biosystems announced plans to merge. The combined company was to be renamed Life Technologies (NASDAQ: LIFE). Invitrogen offered to acquire Applied Biosystems for $6.7 billion in cash and stock. AB shareholders would receive $38 per share in cash and stock, representing a 17 percent premium over the share's closing price on Wednesday, June 11, 2008.
Settings
Other setting(s):
2012